YQYong Qu

Yong Qu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yong Qu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Changzheng Huang

    Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

    1 shared publication
  • Chuxing Chai

    Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    1 shared publication
  • Jinshan Zhan

    Department of Dermatology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan China

    1 shared publication
  • Juanmei Cao

    Department of Dermatology The First Affiliated Hospital of Shihezi University Shihezi China

    1 shared publication
  • Meng Gao

    South China University of Technology

    1 shared publication
  • Min Li

    Department of Hepatobiliary Surgery Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

    1 shared publication

Latest Publications

  • Open Access

    Safe transportation and targeted destruction: Albumin encapsulated aggregation‐induced emission photosensitizer nanoaggregate for tumor photodynamic therapy through mitochondria damage‐triggered pyroptosis

    by Juanmei Cao, Yong Qu, Shaojie Zhu, Jinshan Zhan, Yiting Xu, Yifan Jin, Yuqing Wang, Zhuoxia Li, Chuxing Chai, Xiangwei Wu, et al.

    Photodynamic therapy is a highly recommended alternative treatment for solid tumors, such as cutaneous or luminal tumors, in clinical practice. However, conventional photosensitizers (PSs) often induce undesirable phototoxic effects because of their normal tissue distribution and a reduction in antitumor effects resulting from aggregation‐caused quenching effects. The present study developed a novel nano‐formulated aggregation‐induced emission (AIE)‐characteristic PS, nab‐TTVPHE, which is composed of human serum albumin as a carrier and TTVPHE as a therapeutic agent, as a more effective cancer treatment with lower phototoxic effects. Notably, the reactive oxygen species generated by TTVPHE were shielded by the nanoaggregate structure, and the photodynamic activity was after nanostructure dissociation. Nab‐TTVPHE was actively internalized in tumor cells via secreted protein, acidic and rich in cysteine and released to form nanoaggregates. TTVPHE accumulated in mitochondria, where it triggered mitochondrial damage under light irradiation via its photodynamic activity and induced pyroptosis via the caspase‐3/gasdermin E (GSDME) signaling pathway to kill tumor cells. Therefore, this nano‐formulated AIE‐characteristic PS provides an innovative strategy for cancer treatment with lower phototoxic effect and the ability to boost potential antitumor immunity via GSDME‐mediated pyroptosis.